[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335414-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335414-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","innovative-strategies-in-genitourinary-cancer-the-role-of-oncolytic-viruses","Innovative strategies in genitourinary cancer - the role of oncolytic viruses","","Urinary tumors remain a major health threat due to high prevalence and recurrence, and many patients show limited response to conventional surgery, chemotherapy, and radiotherapy. This review explains how oncolytic viruses can selectively target and destroy cancer cells while triggering strong antitumor immune responses. Focus is placed on recent progress and future prospects for oncolytic viruses across renal, bladder, and prostate cancers, including cowpox virus, adenovirus, measles virus, coxsackievirus, and reovirus.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/innovative-strategies-in-genitourinary-cancer-the-role-of-oncolytic-viruses/335414/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/innovative-strategies-in-genitourinary-cancer-the-role-of-oncolytic-viruses/335414.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are alternative treatments needed for genitourinary tumors?","Question",{"text":63,"@type":64},"High recurrence rates and significant side effects limit traditional therapies, and many patients respond poorly, creating an urgent need for other approaches.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do oncolytic viruses work against cancer?",{"text":68,"@type":64},"Oncolytic viruses exploit cancer-cell characteristics to specifically target and destroy tumor cells, which in turn triggers potent antitumor immune responses.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer types are covered in the review?",{"text":72,"@type":64},"The review focuses on renal, bladder, and prostate cancers and discusses the practical implications of different oncolytic viruses for these diseases.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335414,1790031926,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Review  \nPUBLISHED 11 October 2024 DOI 10.3389/fonc.2024.1461324  \nOPEN ACCESS  \nEDITED BY  \nPeng Qu,  \nNational Institutes of Health (NIH), United States  \nREVIEWED BY  \nShreyansh Jain, Transgene, France Xuesi Hua,  \nUniversity of Michigan, United States Fang Mei,  \nPeking University, China  \n*CORRESPONDENCE  \nJianlin Yuan  \n[jianliny@fmmu.edu.cn](jianliny@fmmu.edu.cn)[ ](jianliny@fmmu.edu.cn)Dongen Ju  \n [dn19951119@163.com](dn19951119@163.com)  \nRECEIVED 08 July 2024  \nACCEPTED 09 September 2024  \nPUBLISHED 11 October 2024  \nCITATION  \nZhang J, Liu K, Zhu Z, Shang S, Wei D, Zheng Y, Zhang L, Liang Y, Ju D and Yuan J (2024) Innovative strategies in genitourinary cancer: the role of oncolytic viruses.  \nFront. Oncol. 14:1461324 .  \ndoi: 10.3389/fonc.2024.1461324  \nCOPYRIGHT  \n© 2024 Zhang, Liu, Zhu, Shang, Wei, Zheng, Zhang, Liang, Ju and Yuan. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nInnovative strategies in genitourinary cancer: the role of oncolytic viruses  \nJie Zhang 1,2, Kepu Liu 2, Zheng Zhu 2, Shihao Shang 2, Di Wei 2, Yu Zheng 2, Lei Zhang 2, Ying Liang 3, Dongen Ju 2* and Jianlin Yuan 2*  \n1College of Life Sciences, Northwest University, Xi’an, Shaanxi, China, 2 Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China, 3 Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China  \nUrinary tumors pose a signiﬁcant health threat because of their high prevalence and recurrence rates. Despite the availability of various treatment options, many patients poorly respond to traditional therapies, highlighting the urgent need for alternative approaches. Oncolytic viruses are promising therapeutic agents. These viruses exploit the unique characteristics of cancer cells to speciﬁcally target and destroy them, thereby triggering potent antitumor immune responses. This review delves into recent advancements and future prospects of oncolytic viruses, focusing on their application in renal, bladder, and prostate cancers. By discussing practical implications and the potential of different viruses, includingthe cowpox virus, adenovirus, measles virus, coxsackievirus, and reovirus, wepave the way for further exploration and reﬁnement of this exciting ﬁeld.  \nKEYWORDS  \noncolytic virus, renal cancer, bladder cancer, prostate cancer, tumor, therapy  \n1 Introduction  \nAs a serious threat to human health, urological tumors require diverse treatment methods. Traditional treatment approaches, including surgery, chemotherapy, and radiotherapy, control the disease to some extent (1) . Onset may be associated with smoking, obesity, insulin resistance, hypertension, and chronic kidney disease. However, issues, such as high recurrence rates and signiﬁcant side effects, continue to affect the medical community and patients. For instance, renal cell carcinoma (RCC), a malignant tumor originating in the kidneys, is generally treated by surgical removal (2) . However, for patients with metastatic RCC, surgery often has a limited efﬁcacy, making adjuvant and targeted therapy crucial supplements (3) . Renal cell carcinoma encompasses a range of histopathological entities, with the most common subtypes being clear cell renal cell carcinoma (80%), peroid renal cell carcinoma (13-20%), and chromophilic renal cell carcinoma (5%) (4) . For localized renal cell carcinoma that has not metastasized, the  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nstandard treatment is surgical resection, and radiofrequency ","cbCaioG1QpS10ctR","https://ap.wps.com/l/cbCaioG1QpS10ctR","pdf",2147344,16,"English","# 1 Introduction\n## Urinary tumors and limitations of traditional therapies\n## Oncolytic viruses as targeted antitumor agents\n# 2 Advances in oncolytic virus applications\n## Renal cancer\n## Bladder cancer\n## Prostate cancer","[{\"question\":\"Why are alternative treatments needed for genitourinary tumors?\",\"answer\":\"High recurrence rates and significant side effects limit traditional therapies, and many patients respond poorly, creating an urgent need for other approaches.\"},{\"question\":\"How do oncolytic viruses work against cancer?\",\"answer\":\"Oncolytic viruses exploit cancer-cell characteristics to specifically target and destroy tumor cells, which in turn triggers potent antitumor immune responses.\"},{\"question\":\"Which cancer types are covered in the review?\",\"answer\":\"The review focuses on renal, bladder, and prostate cancers and discusses the practical implications of different oncolytic viruses for these diseases.\"}]","Innovative strategies in genitourinary cancer - the role of oncolytic viruses | PDF",1790010876]